3 years ago

Cyclic Depsipeptide BE-43547A2: Synthesis and Activity against Pancreatic Cancer Stem Cells

Cyclic Depsipeptide BE-43547A2: Synthesis and Activity against Pancreatic Cancer Stem Cells
Yue Chen, Cuigai Bai, Juan Yang, Yuanjun Sun, Liang Wang, Xiaoqian Guo, Dongmei Li, Yahui Ding, Weicheng Zhang, Chuanke Chong, Xiuwen Su, Jinghan Wang, Ruifei Zhou
Asymmetric total synthesis of the cyclic depsipeptide BE-43547A2 was achieved in 15 linear steps on a 350 mg scale in one batch. The synthesis features the highly diastereoselective construction of an α-hydroxy-β-ketoamide through α-hydroxylation with a d.r. of up to 86:1. BE-43547A2 significantly reduces the percentage of pancreatic cancer stem cells (PCSCs) in Panc-1 cell cultures, and dramatically reduces the tumorsphere-forming capability of Panc-1 cells. An in vivo tumor-initiation assay, a gold standard for cancer stem cell assays, confirmed that BE-43547A2 can abolish the tumorigenesis of Panc-1 cells. The anti-PCSC activity of BE-43547A2 could make this depsipeptide scaffold a promising starting point for discovering new PCSC-targeting drugs. BE the best: Total synthesis of the cyclic depsipeptide BE-43547A2 was achieved in 15 linear steps. BE-43547A2 was shown to reduce the percentage of cancer stem cells in pancreatic cancer cell cultures by 21-fold. In a tumorsphere-formation assay, the number of tumorspheres formed in the BE-43547A2-treated group was about 46-fold less than that in the doxycycline-treated group. A murine tumor-initiation assay confirmed that BE-43547A2 can abolish tumorigenesis.

Publisher URL: http://onlinelibrary.wiley.com/resolve/doi

DOI: 10.1002/anie.201709744

You might also like
Never Miss Important Research

Researcher is an app designed by academics, for academics. Create a personalised feed in two minutes.
Choose from over 15,000 academics journals covering ten research areas then let Researcher deliver you papers tailored to your interests each day.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.